How Optical Genome Mapping is transforming leukemia diagnosis by revealing hidden genetic abnormalities with unprecedented clarity.
Revolutionary Optical Genome Mapping technology reveals structural variants in ALL patient-derived xenograft models, uncovering new insights into treatment resistance.